Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
2.800
+0.010 (0.36%)
Aug 14, 2025, 1:50 PM - Market open
Cellectis Market Cap
Cellectis has a market cap or net worth of $209.71 million as of August 14, 2025. Its market cap has increased by 32.14% in one year.
Market Cap
209.71M
Enterprise Value
240.79M
1-Year Change
32.14%
Ranking
Category
Stock Price
$2.80
Market Cap Chart
Since March 25, 2015, Cellectis's market cap has decreased from $1.34B to $209.71M, a decrease of -84.40%. That is a compound annual growth rate of -16.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 201.80M | 55.47% |
| Dec 31, 2024 | 129.80M | -24.18% |
| Dec 29, 2023 | 171.20M | 78.89% |
| Dec 30, 2022 | 95.70M | -74.09% |
| Dec 31, 2021 | 369.30M | -67.88% |
| Dec 31, 2020 | 1.15B | 58.27% |
| Dec 31, 2019 | 726.40M | 2.87% |
| Dec 31, 2018 | 706.10M | -31.45% |
| Dec 29, 2017 | 1.03B | 72.73% |
| Dec 30, 2016 | 596.30M | -43.80% |
| Dec 31, 2015 | 1.06B | -21.04% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |